关注
Sema Türker
Sema Türker
Bahcesehir University
在 med.bau.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors?
V Yazisiz, G Arslan, İH Ozbudak, S Turker, F Erbasan, AB Avci, ...
Rheumatology international 30, 1317-1324, 2010
1452010
Platelet activation in subjects with impaired glucose tolerance
E Coban, S Kucuktag, S Basyigit
Platelets 18 (8), 591-594, 2007
562007
Differential changes in Substance P, VIP as well as neprilysin levels in patients with gastritis or ulcer
N Erin, S Türker, Ö Elpek, B Yıldırım
Peptides 35 (2), 218-224, 2012
282012
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ...
BMC cancer 23 (1), 136, 2023
202023
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer
N Erin, S Türker, Ö Elpek, B Yildirim
Experimental and therapeutic medicine 15 (2), 1999-2005, 2018
142018
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.
B Hacioglu, O Kostek, S Karabulut, D Tastekin, C Alandag, B Akagunduz, ...
Journal of BU ON.: official journal of the Balkan Union of Oncology 25 (4 …, 2020
112020
The impact of lymph node ratio on overall survival in patients with colorectal cancer
Gİ İmamoğlu, A Oğuz, S Cimen, T Eren, C Karacin, D Colak, M Altşbaş, ...
Journal of Cancer Research and Therapeutics 17 (4), 1069-1074, 2021
102021
The relation between inflammation-based parameters and survival in metastatic pancreatic cancer
S Turker, E Cilbir, DC Guven, C Karacin, S Yalcin
Journal of Cancer Research and Therapeutics 17 (2), 510-515, 2021
102021
The effect of HER2-low status on pathological complete response and survival in triple-negative breast cancer: a systemic review and meta-analysis
Y Ergun, B Akagunduz, C Karacin, S Turker, G Ucar
Clinical Breast Cancer 23 (6), 567-575, 2023
72023
Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
S Turker, E Cilbir, C Karacin, M Altinbas
Journal of Cancer Research and Therapeutics 16 (3), 690-692, 2020
72020
" Squamos cell lung cancer" case applying with dyspepsia complaints
S Turker, H Sahinli, P Perkin, D Yazilitas, NO Koklu, GI Imamoglu, ...
Journal of Oncological Sciences 4 (3), 147-148, 2018
72018
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer
M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ...
Tumori Journal 107 (5), 416-423, 2021
62021
Tumor‐to‐tumor metastasis: Breast cancer metastasis to lung cancer.
S Turker, E Çılbır, KB Yilmaz, E Yetişgin, G İmamoğlu, K İnan, H Şahinli, ...
Breast Journal 26 (3), 2020
62020
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
SA Esen, Y Ergun, C Erol, R Arikan, MM Er, MM Atci, A Topçu, G Uçar, ...
Bosnian journal of basic medical sciences 22 (5), 818, 2022
42022
Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology …
A Alkan, A Yaşar, ZG Güç, M Gürbüz, T Başoğlu, S Sezgin Göksu, ...
European Journal of Cancer Care 29 (6), e13296, 2020
42020
Predictors of neoplasia in colonic wall thickening detected via computerized tomography
C Karacin, S Türker, T Eren, GI Imamoglu, K Yılmaz, Y Coskun, SO Gunes, ...
Cureus 12 (9), 2020
42020
The mean platelet volume to lymphocyte ratio: a new prognostic marker in resected gastric cancer
H Şahinli, S Türker, T Eren, E Cilbir, M ALTINBAŞ
EJMI 4, 155-160, 2020
42020
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
O Avcı, Y İriağaç, E Çavdar, K Karaboyun, M Araz, T Şakalar, E Değerli, ...
Journal of Geriatric Oncology 14 (8), 101604, 2023
32023
Trastuzumab±Capecitabine maintenance after the first-line treatment of HER2-positive advanced gastric cancer: retrospective observational real-life data of Turkish Oncology Group
M Gürbüz, E Akkuş, A Sakin, S Urvay, AG Demiray, S Şahin, T Şakalar, ...
Journal of Gastrointestinal Cancer 53 (2), 282-288, 2022
32022
Real-life analysis of efficacy and safety of everolimus plus exemestane in hormone receptor-positive, human epidermal growth factor receptor-2-negative metastatic breast cancer …
A Bilici, M Uysal, S Menekse, S Akin, F Yildiz, M Turan, S Sezgin Goksu, ...
Cancer Investigation 40 (2), 199-209, 2022
32022
系统目前无法执行此操作,请稍后再试。
文章 1–20